Invention Application
- Patent Title: Immunogenic peptides of foot-and-mouth disease viruses
- Patent Title (中): 口蹄疫病毒的免疫原性肽
-
Application No.: US10985210Application Date: 2004-11-09
-
Publication No.: US20050058656A1Publication Date: 2005-03-17
- Inventor: Roberto Correa , Hans-Robert Hehnen , Eberhard Pfaff , Armin Saalmuller , Thomas Pauly , Bettina Hohlich , Bernadette Glatthaar-Saalmuller , Karl-Heinz Wiesmuller
- Applicant: Roberto Correa , Hans-Robert Hehnen , Eberhard Pfaff , Armin Saalmuller , Thomas Pauly , Bettina Hohlich , Bernadette Glatthaar-Saalmuller , Karl-Heinz Wiesmuller
- Applicant Address: DE Leverkusen
- Assignee: Bayer Aktiengesellschaft
- Current Assignee: Bayer Aktiengesellschaft
- Current Assignee Address: DE Leverkusen
- Priority: DE19638044.8 19960918
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/135 ; C07K14/09 ; C12N15/42 ; A61K39/12 ; C07K14/005
Abstract:
The present invention relates to FMDC vaccine based on peptides having a sequence of at least 8 amino acids, which corresponds to a partial sequence of the non-structural protein region of FMDV, which was selected by immunoreactivity with FMDV-specific antibodies or by immunoreactivity with FMDV-specific T lymphocytes, and to their production and their use.
Information query
